Composition Containing Poria Cocos Peel Extract for Treating Neurodegenerative Disorders
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,864,238 | Composition Containing Poria Cocos Peel Extract for Treating Neurodegenerative Disorders In force · High confidence UsedRemaining | Neurobo Pharmaceuticals, Inc. | In force | High confidence | ||
| Application 17/097,592 | Composition Containing Poria Cocos Peel Extract for Treating Neurodegenerative Disorders Abandoned Abandoned Jan 4, 2023 | Neurobo Pharmaceuticals, Inc. | Abandoned | Abandoned Jan 4, 2023 |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Neurobo Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.